戻る Agenda
FDA Townhall
Session Chair(s)
Katherine Tyner, PHD
Senior Director, Regulatory Policy Leader EMEA & CMC
Johnson & Johnson, Netherlands
FDA maintains a global presence to facilitate collaborations amongst regulators and speed the development of critical medical products. In Europe, FDA uses multiple platforms and mechanisms to collaborate on a wide range of activities from technical exchange, to reliance on GMP inspections, to discussions of emerging and innovative technologies. In this session, you will hear about current FDA activities and priorities for the coming years.?
Speaker(s)
FDA in Your Neighborhood: Overview of the FDA Europe Office
Katherine Marie Serrano
FDA, United States
Director, Europe Office, Office of Global Policy and Strategy
FDA Europe Office Priorities 2024
Shannon Thor, PHARMD, MS
FDA, United States
Deputy Director, Office of Global Policy & Strategy, Europe Office
FDA – EMA Collaborations
Katherine Tyner, PHD
Johnson & Johnson, Netherlands
Senior Director, Regulatory Policy Leader EMEA & CMC
Moderator
Ioana Ulea, LLM
FDA, Belgium
Senior Policy Advisor